Cleared Traditional

K170755 - DRX-Revolution Nano Mobile X-ray System

K170755 is the FDA 510(k) clearance for DRX-Revolution Nano Mobile X-ray System by Carestream Health, Inc.. It is a Class 2 Radiology device (product code IZL) cleared through the Traditional 510(k) pathway after a 100-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
100d
Days
Class 2
Risk

K170755 is an FDA 510(k) clearance for the DRX-Revolution Nano Mobile X-ray System. Classified as System, X-ray, Mobile (product code IZL), Class II - Special Controls.

Submitted by Carestream Health, Inc. (Rochester, US). The FDA issued a Cleared decision on June 21, 2017 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1720 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Carestream Health, Inc. devices

Submission Details

510(k) Number K170755 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2017
Decision Date June 21, 2017
Days to Decision 100 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 107d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZL System, X-ray, Mobile
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZL System, X-ray, Mobile

All 117
Devices cleared under the same product code (IZL) and FDA review panel - the closest regulatory comparables to K170755.
DRX-Revolution Nano Mobile X-ray System
K173924 · Carestream Health, Inc. · Feb 2018
DRAGON X SPSL4HC, DRAGON X SPSL8HC
K173299 · Sedecal., Sa. · Jan 2018
Optima XR240amx, AutoGrid
K173602 · Ge Medical Systems, LLC · Jan 2018
GM85
K171119 · Samsung Electronics Co., Ltd. · May 2017
FDR AQRO (DR-XD 1000)
K170858 · Fujifilm Medical Systems U.S.A, Inc. · Apr 2017
Digital Diagnostic Mobile X-ray System
K162278 · Samsung Electronics Co., Ltd. · Nov 2016